Probiotic Colonization of the Adherent Mucus Layer of HT29MTXE12 Cells Attenuates Campylobacter Jejuni Virulence Properties

Overview

Journal Infect Immun

Publisher American Society for Microbiology

Specialty Allergy & Immunology

Date 2010 Mar 24

PMID 20308300

Citations 47

Authors

Abofu Alemka

Marguerite Clyne

Fergus Shanahan

Thomas Tompkins

Nicolae Corcionivoschi

Billy Bourke

Affiliations

Soon will be listed here.

Abstract

The HT29MTXE12 (E12) cell line harbors an adherent mucus layer, providing a novel technique to model mucosal infection in vitro. In this study, we have characterized the interaction of Campylobacter jejuni with the E12 cell line and exploited its unique mucus layer to examine the potential efficacy of probiotic treatment to attenuate C. jejuni virulence properties. C. jejuni 81-176 colonized and reproduced in E12 mucus. Adhesion to and internalization of C. jejuni were enhanced in E12 cells harboring mucus compared to parental cells without mucus. Translocation of C. jejuni occurred at early time points following infection. C. jejuni aligned with tight junctions and colocalized with the tight junction protein occludin, suggesting a paracellular route of translocation. Probiotic strains Lactobacillus rhamnosus R0011, Lactobacillus helveticus R0052, Lactobacillus salivarius AH102, Bifidobacterium longum AH1205, a commercial combination of L. rhamnosus R0011 and L. helveticus R0052 (Lacidofil), and a cocktail consisting of L. rhamnosus, L. helveticus, and L. salivarius (RhHeSa) colonized E12 mucus and bound to underlying cells. Probiotics attenuated C. jejuni association with and internalization into E12 cells and translocation to the basolateral medium of transwells. Live bacteria and prolonged precolonization of E12 cells with probiotics were necessary for probiotic action. These results demonstrate the potential for E12 cells as a model of mucosal pathogenesis and provide a rationale for the further investigation of probiotics as prophylaxis against human campylobacteriosis.

Citing Articles

In vitro investigations on interference of selected probiotic candidates with Campylobacter jejuni adhesion and invasion of primary chicken derived cecal and Caco-2 cells.

Willer T, Han Z, Pielsticker C, Rautenschlein S Gut Pathog. 2024; 16(1):30.

PMID: 38907359 PMC: 11191211. DOI: 10.1186/s13099-024-00623-x.

Survival Time of in Broiler Crops.

Nishii M, Yasutomi M J Poult Sci. 2024; 61:2024016.

PMID: 38827264 PMC: 11136615. DOI: 10.2141/jpsa.2024016.

Uptake of by Intestinal Epithelia.

Friebel J, Schinnerling K, Weigt K, Heldt C, Fromm A, Bojarski C Int J Mol Sci. 2023; 24(7).

PMID: 37047170 PMC: 10094206. DOI: 10.3390/ijms24076197.

Transcriptome Analysis of Arcobacter butzleri Infection in a Mucus-Producing Human Intestinal Model.

Buzzanca D, Alessandria V, Botta C, Seif Zadeh N, Ferrocino I, Houf K Microbiol Spectr. 2023; 11(1):e0207122.

PMID: 36622176 PMC: 9927503. DOI: 10.1128/spectrum.02071-22.

The Bioavailability of Glycyrrhizinic Acid Was Enhanced by Probiotic R0011 Supplementation in Liver Fibrosis Rats.

Li H, Wang J, Fu Y, Zhu K, Dong Z, Shan J Nutrients. 2022; 14(24).

PMID: 36558437 PMC: 9782010. DOI: 10.3390/nu14245278.

References

Corry J, Post D, Colin P, Laisney M . Culture media for the isolation of campylobacters. Int J Food Microbiol. 1995; 26(1):43-76. DOI: 10.1016/0168-1605(95)00044-k. View

Smith J, Bayles D . Postinfectious irritable bowel syndrome: a long-term consequence of bacterial gastroenteritis. J Food Prot. 2007; 70(7):1762-9. DOI: 10.4315/0362-028x-70.7.1762. View

OHara A, Shanahan F . Mechanisms of action of probiotics in intestinal diseases. ScientificWorldJournal. 2007; 7:31-46. PMC: 5901104. DOI: 10.1100/tsw.2007.26. View

Watson R, Galan J . Campylobacter jejuni survives within epithelial cells by avoiding delivery to lysosomes. PLoS Pathog. 2008; 4(1):e14. PMC: 2323279. DOI: 10.1371/journal.ppat.0040014. View

Lesuffleur T, Barbat A, Dussaulx E, ZWEIBAUM A . Growth adaptation to methotrexate of HT-29 human colon carcinoma cells is associated with their ability to differentiate into columnar absorptive and mucus-secreting cells. Cancer Res. 1990; 50(19):6334-43. View

Szymanski C, King M, Haardt M, Armstrong G . Campylobacter jejuni motility and invasion of Caco-2 cells. Infect Immun. 1995; 63(11):4295-300. PMC: 173610. DOI: 10.1128/iai.63.11.4295-4300.1995. View

Byrne C, Clyne M, Bourke B . Campylobacter jejuni adhere to and invade chicken intestinal epithelial cells in vitro. Microbiology (Reading). 2007; 153(Pt 2):561-569. DOI: 10.1099/mic.0.2006/000711-0. View

Wagner R, Johnson S, Kurniasih Rubin D . Probiotic bacteria are antagonistic to Salmonella enterica and Campylobacter jejuni and influence host lymphocyte responses in human microbiota-associated immunodeficient and immunocompetent mice. Mol Nutr Food Res. 2008; 53(3):377-88. DOI: 10.1002/mnfr.200800101. View

Barragan A, Brossier F, Sibley L . Transepithelial migration of Toxoplasma gondii involves an interaction of intercellular adhesion molecule 1 (ICAM-1) with the parasite adhesin MIC2. Cell Microbiol. 2005; 7(4):561-8. DOI: 10.1111/j.1462-5822.2005.00486.x. View

10.

Willis W, Reid L . Investigating the effects of dietary probiotic feeding regimens on broiler chicken production and Campylobacter jejuni presence. Poult Sci. 2008; 87(4):606-11. DOI: 10.3382/ps.2006-00458. View

11.

van Alphen L, Bleumink-Pluym N, Rochat K, van Balkom B, Wosten M, van Putten J . Active migration into the subcellular space precedes Campylobacter jejuni invasion of epithelial cells. Cell Microbiol. 2007; 10(1):53-66. DOI: 10.1111/j.1462-5822.2007.01014.x. View

12.

Ng S, Hart A, Kamm M, Stagg A, Knight S . Mechanisms of action of probiotics: recent advances. Inflamm Bowel Dis. 2008; 15(2):300-10. DOI: 10.1002/ibd.20602. View

13.

Keely S, Rullay A, Wilson C, Carmichael A, Carrington S, Corfield A . In vitro and ex vivo intestinal tissue models to measure mucoadhesion of poly (methacrylate) and N-trimethylated chitosan polymers. Pharm Res. 2005; 22(1):38-49. DOI: 10.1007/s11095-004-9007-1. View

14.

Sherman P, Johnson-Henry K, Yeung H, Ngo P, Goulet J, Tompkins T . Probiotics reduce enterohemorrhagic Escherichia coli O157:H7- and enteropathogenic E. coli O127:H6-induced changes in polarized T84 epithelial cell monolayers by reducing bacterial adhesion and cytoskeletal rearrangements. Infect Immun. 2005; 73(8):5183-8. PMC: 1201237. DOI: 10.1128/IAI.73.8.5183-5188.2005. View

15.

Chaveerach P, Lipman L, van Knapen F . Antagonistic activities of several bacteria on in vitro growth of 10 strains of Campylobacter jejuni/coli. Int J Food Microbiol. 2003; 90(1):43-50. DOI: 10.1016/s0168-1605(03)00170-3. View

16.

McAuley J, Linden S, Png C, King R, Pennington H, Gendler S . MUC1 cell surface mucin is a critical element of the mucosal barrier to infection. J Clin Invest. 2007; 117(8):2313-24. PMC: 1913485. DOI: 10.1172/JCI26705. View

17.

Hu L, Kopecko D . Campylobacter jejuni 81-176 associates with microtubules and dynein during invasion of human intestinal cells. Infect Immun. 1999; 67(8):4171-82. PMC: 96722. DOI: 10.1128/IAI.67.8.4171-4182.1999. View

18.

Konkel M, Kim B, Garvis S . Bacterial secreted proteins are required for the internaliztion of Campylobacter jejuni into cultured mammalian cells. Mol Microbiol. 1999; 32(4):691-701. DOI: 10.1046/j.1365-2958.1999.01376.x. View

19.

Tu Q, McGuckin M, Mendz G . Campylobacter jejuni response to human mucin MUC2: modulation of colonization and pathogenicity determinants. J Med Microbiol. 2008; 57(Pt 7):795-802. DOI: 10.1099/jmm.0.47752-0. View

20.

Mack D, Ahrne S, Hyde L, Wei S, Hollingsworth M . Extracellular MUC3 mucin secretion follows adherence of Lactobacillus strains to intestinal epithelial cells in vitro. Gut. 2003; 52(6):827-33. PMC: 1773687. DOI: 10.1136/gut.52.6.827. View